Pharmaceutical Technology Europe-09-01-2011

Pharmaceutical Technology Europe
Special Feature

September 01, 2011

Direct dosing APIs during R&D studies can reduce the overall testing time of a drug candidate by allowing for a greater throughput of compounds through the R&D department.

Pharmaceutical Technology Europe
Special Feature

September 01, 2011

The increasing cost of crucial manufacturing input factors, such as energy and raw materials, has been a severe threat to several companies.

Industry Insider
Pharmaceutical Technology Europe

September 01, 2011

The rising cost of healthcare has complicated the introduction of new, innovative drugs and other medical technologies. While the medical impact of these healthcare advances cannot be denied, governments and healthcare policy makers have found it difficult to sustain the funding of these expensive treatments.

Interview
Pharmaceutical Technology Europe

September 01, 2011

Elham Blouet from Roquette explains the importance of carbohydrates for injection and the challenges in this niche market.

Pharmaceutical Technology Europe

By providing an information "fingerprint", infrared red spectroscopy is a useful tool for identifying counterfeit pharmaceuticals. The authors identify best practices for ensuring compliance.

Pharmaceutical Technology Europe
Special Feature

September 01, 2011

The increased trend of outsourcing coupled with a relatively strong economy has seen the fine chemicals market grow at a very high level when compared to historical data.

News
Pharmaceutical Technology Europe

September 01, 2011

Friends in regulation

Pharmaceutical Technology Europe

By introducing a Patent Box scheme that offers reduced taxes to innovative companies, the UK government hopes to encourage investment in the country.

Special Feature
Pharmaceutical Technology Europe

September 01, 2011

The market for HPAPIs is growing rapidly with the research industry's emphasis on oncology.

Pharmaceutical Technology Europe
Special Feature

September 01, 2011

Highly potent APIs (HPAPIs) represent a growing area of interest for the pharma industry. Mark Griffiths, CEO of Carbogen Amcis AG, explains why.

Pharmaceutical Technology Europe
Special Feature

September 01, 2011

We're all familiar with traditional pills and medicines, but how about medicated chewing gum? Marc Ribe of Cafosa Gum explains how APIs can be incorporated into a novel dosage form that can aid patient compliance.

Interview
Pharmaceutical Technology Europe

September 01, 2011

Henrik Schwartzbach, senior process technologist at GEA Niro, explins why spray drying is seeing increased uptake in the pharma industry.

Pharmaceutical Technology Europe
Special Feature

September 01, 2011

Recently, there have been many innovations in the latest techniques and technologies in API purification. In particular, the trend to single-use systems has had a significant impact on processes.

Pharmaceutical Technology Europe

Strategies to minimise particle levels in the finished product when using single-use technologies downstream of final filters.

Pharmaceutical Technology Europe

September 01, 2011

Summer can often feel like a quiet month for the pharma industry in Europe.